Skip to main content
. Author manuscript; available in PMC: 2011 Apr 8.
Published in final edited form as: Urology. 2009 Dec 5;75(2):414–418. doi: 10.1016/j.urology.2009.07.1353

Table 1.

Patient demographic information.

Clinically localized, biopsy Gleason score ≥ 7 and no significant comorbidities (N = 3959) T1b-T2b N0M0, biopsy Gleason score ≤ 7 and PSA ≤ 15 ng/ml (N = 3536) T1c PCa (N = 2330)
Mean Age (range) 61 (36–80) 61 (36–80) 60 (36–78)
Race (% White) 3735 (95%) 3336 (95%) 2168 (93%)
Median PSA (range) 5.6 (0.0–98.0) 5.4 (0.0–15.0) 5.5 (0.0–66.0)
Biopsy Gleason > 6 694 (18%) 596 (17%) 415 (18%)